Literature DB >> 7764457

Cytochromes P450 and drug resistance.

J Doehmer1, A R Goeptar, N P Vermeulen.   

Abstract

Cytochromes P450 are the key enzymes for activating and inactivating many drugs, in particular anticancer drugs. Therefore, individual expression levels of cytochromes P450 may play a crucial role in drug safety and drug efficacy. Overexpression of cytochrome P450 may yield rapid turnover and elimination of drugs before the target site was reached and any pharmacological effect is observed. Therefore, it may be vital to know the individual cytochrome P450 status in order to select the appropriate drug before drug resistance occurs. Expression levels and activity of cytochromes P450 depend on many different factors. These factors include tissue and organ specific expression, sex- and age-dependent expression, genetic differences yielding polymorphic forms, competitive inhibition or induction of cytochromes P450 due to multiple drug interaction, nutrition and diet. Genetically engineered test cells defined for cytochromes P450 are available for studying drugs for metabolic activation and for identifying the metabolically competent cytochrome P450 isoform.

Mesh:

Substances:

Year:  1993        PMID: 7764457     DOI: 10.1007/BF00744673

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  23 in total

Review 1.  The role of individual human cytochromes P450 in drug metabolism and clinical response.

Authors:  S Cholerton; A K Daly; J R Idle
Journal:  Trends Pharmacol Sci       Date:  1992-12       Impact factor: 14.819

Review 2.  Evolution of the P450 gene superfamily: animal-plant 'warfare', molecular drive and human genetic differences in drug oxidation.

Authors:  F J Gonzalez; D W Nebert
Journal:  Trends Genet       Date:  1990-06       Impact factor: 11.639

Review 3.  Metabolism and reactions of quinoid anticancer agents.

Authors:  G Powis
Journal:  Pharmacol Ther       Date:  1987       Impact factor: 12.310

4.  In vitro metabolism of etoposide (VP-16-213) by liver microsomes and irreversible binding of reactive intermediates to microsomal proteins.

Authors:  N Haim; J Nemec; J Roman; B K Sinha
Journal:  Biochem Pharmacol       Date:  1987-02-15       Impact factor: 5.858

5.  Regulation of rat hepatic cytochrome P-450: age-dependent expression, hormonal imprinting, and xenobiotic inducibility of sex-specific isoenzymes.

Authors:  D J Waxman; G A Dannan; F P Guengerich
Journal:  Biochemistry       Date:  1985-07-30       Impact factor: 3.162

6.  Major isozymes of rat liver microsomal cytochrome P-450 involved in the N-oxidation of N-isopropyl-alpha-(2-methylazo)-p-toluamide, the azo derivative of procarbazine.

Authors:  R A Prough; M I Brown; G A Dannan; F P Guengerich
Journal:  Cancer Res       Date:  1984-02       Impact factor: 12.701

7.  Rat hepatic cytochrome P-450 isozyme specificity for the metabolism of the steroid sulfate, 5 alpha-androstane-3 alpha, 17 beta-diol-3,17-disulfate.

Authors:  D E Ryan; R Dixon; R H Evans; L Ramanathan; P E Thomas; A W Wood; W Levin
Journal:  Arch Biochem Biophys       Date:  1984-09       Impact factor: 4.013

8.  Biotransformation of caffeine and theophylline in mammalian cell lines genetically engineered for expression of single cytochrome P450 isoforms.

Authors:  U Fuhr; J Doehmer; N Battula; C Wölfel; C Kudla; Y Keita; A H Staib
Journal:  Biochem Pharmacol       Date:  1992-01-22       Impact factor: 5.858

Review 9.  Free radical formation by antitumor quinones.

Authors:  G Powis
Journal:  Free Radic Biol Med       Date:  1989       Impact factor: 7.376

10.  Genetically engineered V79 Chinese hamster cells metabolically activate the cytostatic drugs cyclophosphamide and ifosfamide.

Authors:  J Doehmer; A Seidel; F Oesch; H R Glatt
Journal:  Environ Health Perspect       Date:  1990-08       Impact factor: 9.031

View more
  1 in total

1.  Structural Dynamics of Cytochrome P450 3A4 in the Presence of Substrates and Cytochrome P450 Reductase.

Authors:  Julie Ducharme; Irina F Sevrioukova; Christopher J Thibodeaux; Karine Auclair
Journal:  Biochemistry       Date:  2021-07-01       Impact factor: 3.321

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.